The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of DNL151...
The objectives of this study are to assess the efficacy, safety and tolerability of VY-AADC02 in Patients with Parkinson's Disease...
The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094...
The primary objective of this study is to evaluate the safety and tolerability of a range of single and 13...
To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis
This study evaluates the safety and tolerability of CDNF in patients with Parkinson's disease, when dosed directly into the brain...
This study is an extension to the HP-CD-CL-2002 clinical study. It evaluates the long-term safety and tolerability of CDNF in...
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available...
The objective of this study is to evaluate the performance of novel DBS programming methods compared to traditional programming methods.
The purpose of this study is to evaluate the effect of TAK-071 when compared to placebo on gait in patients...
The purpose of this study is to describe the safety and efficacy of opicapone plus standard of care in elderly...
The purpose of this study is to evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality...
This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinsons' Disease.
English (USA)